"Commercial stem cells" damage medicine: medicine is aware.
A recent Editorial in the NEJM on the flourishing of stem cell clinics providing unproven treatments ona commercial basis and the widespread use of fake cell therapies in the US resonates with worldwide concerns on unproven therapies and in Italy, with the recent and luckily finished “Stamina case”. The article brings into focus a resurgence of concern, awareness and willingness to stand up of the broad medical community, in a scenario in which fundamental values of science and medicine are at stake.